2018
Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry
Tamborlane WV, Chang P, Kollman C, Klingensmith GJ, Ruedy K, Gal RL, Van Name M, Bacha F, Willi S, Beck RW, Consortium F. Eligibility for clinical trials is limited for youth with type 2 diabetes: Insights from the Pediatric Diabetes Consortium T2D Clinic Registry. Pediatric Diabetes 2018, 19: 1379-1384. PMID: 30175440, DOI: 10.1111/pedi.12763.Peer-Reviewed Original ResearchConceptsType 2 diabetesT2D durationT2D patientsClinical trialsEligibility criteriaPlacebo-assigned subjectsPercentage of patientsCurrent clinical trialsRestrictive eligibility criteriaBaseline HbA1cHbA1c levelsClinical characteristicsClinic registryRegistry enrollmentInvestigational treatmentPatientsCurrent trialTrialsNew drugsMonthsHbA1cRatio of femaleDiabetesRegistryEnrollment
2016
Stress and Coping Predicts Adjustment and Glycemic Control in Adolescents with Type 1 Diabetes
Jaser SS, Patel N, Xu M, Tamborlane WV, Grey M. Stress and Coping Predicts Adjustment and Glycemic Control in Adolescents with Type 1 Diabetes. Annals Of Behavioral Medicine 2016, 51: 30-38. PMID: 27496164, PMCID: PMC5253083, DOI: 10.1007/s12160-016-9825-5.Peer-Reviewed Original ResearchConceptsDiabetes-related stressQuality of lifeType 1 diabetesGlycemic controlSymptoms of depressionDepressive symptomsMedical chartsDiabetesSymptomsType 1Coping strategiesPrimary control copingSignificant predictorsAdolescentsDisengagement coping strategiesMonthsPoor qualityDepressionOutcomesAdolescent usePredictorsPsychosocial predictors and moderators of weight management programme outcomes in ethnically diverse obese youth
Taylor JH, Xu Y, Li F, Shaw M, Dziura J, Caprio S, Tamborlane WV, Nowicka P, Savoye M. Psychosocial predictors and moderators of weight management programme outcomes in ethnically diverse obese youth. Pediatric Obesity 2016, 12: 453-461. PMID: 27384496, PMCID: PMC5568975, DOI: 10.1111/ijpo.12165.Peer-Reviewed Original ResearchConceptsClinic careObese youthOutpatient clinic careAbnormal glucose toleranceObesity treatment outcomesObesity intervention programFamily functioningLifestyle interventionGlucose toleranceChildhood obesityLifestyle programTreatment outcomesPsychosocial predictorsIdentification of factorsIntervention programsIntervention outcomesOutcomesPoor family functioningTreatment effectsHigh anxietyBaselineCareMonthsIntervention
2015
Body Mass Index Changes in Youth in the First Year after Type 1 Diabetes Diagnosis
Gregg B, Connor CG, Ruedy KJ, Beck RW, Kollman C, Schatz D, Cengiz E, Harris B, Tamborlane WV, Klingensmith GJ, Lee JM, Consortium P. Body Mass Index Changes in Youth in the First Year after Type 1 Diabetes Diagnosis. The Journal Of Pediatrics 2015, 166: 1265-1269.e1. PMID: 25919735, DOI: 10.1016/j.jpeds.2015.02.036.Peer-Reviewed Original ResearchConceptsBody mass indexBMI z-scoreZ-scoreBody mass index (BMI) changeMeasures of BMIPediatric Diabetes ConsortiumRegain of weightFirst yearType 1 diabetesDelivery modeAdditional weight gainDiabetes durationClinical characteristicsMass indexT1D diagnosisBMI trajectoriesProspective longitudinal dataUS CentersType 1Weight gainSignificant positive changesDiagnosisMonthsSocioeconomic statusDemographic characteristics
2013
Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis
Cengiz E, Connor CG, Ruedy KJ, Beck RW, Kollman C, Klingensmith GJ, Tamborlane WV, Lee JM, Haller MJ, Consortium F. Pediatric diabetes consortium T1D New Onset (NeOn) study: clinical outcomes during the first year following diagnosis. Pediatric Diabetes 2013, 15: 287-293. PMID: 23944865, PMCID: PMC3844085, DOI: 10.1111/pedi.12068.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentChildChild, PreschoolCohort StudiesDiabetes Mellitus, Type 1Diabetic KetoacidosisDrug MonitoringFemaleFollow-Up StudiesGlycated HemoglobinHumansHyperglycemiaHypoglycemiaHypoglycemic AgentsIncidenceInfantInsulinKaplan-Meier EstimateMaleProportional Hazards ModelsProspective StudiesUnited StatesConceptsPediatric Diabetes ConsortiumDiabetic ketoacidosisClinical outcomesNatural historyFirst yearCourse of T1DDiagnosis of T1D.Onset of T1DTime of diagnosisSevere hypoglycemic eventsType 1 diabetesMean HbA1cMulticenter studyHypoglycemic eventsClinical measuresLarge cohortIntervention studiesDiagnosisFuture interventionsMonthsOnset StudyHbA1cT1D.T1DOutcomes
2011
Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study Results from the 6-month continuation phase
Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Perkins BA, Welsh JB, Willi SM, Wood MA, . Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study Results from the 6-month continuation phase. Diabetes Care 2011, 34: 2403-2405. PMID: 21933908, PMCID: PMC3198292, DOI: 10.2337/dc11-1248.Peer-Reviewed Original Research
2010
Continuous Glucose Monitoring in Youth with Type 1 Diabetes: 12-Month Follow-Up of the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial
Chase HP, Beck RW, Xing D, Tamborlane WV, Coffey J, Fox LA, Ives B, Keady J, Kollman C, Laffel L, Ruedy KJ. Continuous Glucose Monitoring in Youth with Type 1 Diabetes: 12-Month Follow-Up of the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Randomized Trial. Diabetes Technology & Therapeutics 2010, 12: 507-515. PMID: 20597824, DOI: 10.1089/dia.2010.0021.Peer-Reviewed Original ResearchConceptsContinuous glucose monitoringUse of CGMDays/weekCGM useMonth 12Glucose monitoringSevere hypoglycemic eventsType 1 diabetesJuvenile Diabetes Research Foundation Continuous Glucose MonitoringBaseline hemoglobinGlycemic controlSevere hypoglycemiaPediatric populationHypoglycemic eventsSubjects 8Extension studyType 1MonthsT1DGreater improvementTrialsWeeksGreater satisfactionSubjectsSatisfaction Scale
2005
A Randomized Multicenter Trial Comparing the GlucoWatch Biographer With Standard Glucose Monitoring in Children With Type 1 Diabetes
Chase HP, Beck R, Tamborlane W, Buckingham B, Mauras N, Tsalikian E, Wysocki T, Weinzimer S, Kollman C, Ruedy K, Xing D. A Randomized Multicenter Trial Comparing the GlucoWatch Biographer With Standard Glucose Monitoring in Children With Type 1 Diabetes. Diabetes Care 2005, 28: 1101-1106. PMID: 15855573, DOI: 10.2337/diacare.28.5.1101.Peer-Reviewed Original ResearchConceptsUsual care groupStandard glucose monitoringTimes/weekCare groupGlucose monitoringSevere hypoglycemiaSevere hypoglycemia eventsType 1 diabetesTrial ComparingGlycemic controlHypoglycemia eventsSkin reactionsType 1HypoglycemiaStudy outcomesSkin irritationGlucoWatch G2 BiographerMonthsSensor useWeeksGroupGlucoWatch biographerExcessive alarmsDiabetesMean value